Compare THR & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THR | PGEN |
|---|---|---|
| Founded | 1954 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2011 | 2013 |
| Metric | THR | PGEN |
|---|---|---|
| Price | $52.68 | $3.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $54.00 | $7.67 |
| AVG Volume (30 Days) | 596.9K | ★ 3.9M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.97 | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $276,181,000.00 | $230,981,000.00 |
| Revenue This Year | $6.07 | $342.78 |
| Revenue Next Year | $6.17 | $478.46 |
| P/E Ratio | $42.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.05 | $1.11 |
| 52 Week High | $58.56 | $5.47 |
| Indicator | THR | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 67.30 | 36.23 |
| Support Level | $25.10 | $3.49 |
| Resistance Level | $53.52 | $5.16 |
| Average True Range (ATR) | 2.90 | 0.37 |
| MACD | -0.13 | -0.13 |
| Stochastic Oscillator | 42.77 | 5.72 |
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.